Otsuka (OTSKF) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. operates as a global healthcare group, with principal activities spanning pharmaceuticals, nutraceuticals and consumer products. The company’s pharmaceutical arm researches, develops and markets prescription drugs primarily in the fields of neuroscience, oncology, cardiovascular and renal diseases. Its nutraceutical division produces a range of functional beverages and nutritional supplements, while its consumer products include beverages and food items sold under well-known brands across Asia and beyond.

In pharmaceuticals, Otsuka has built a portfolio that combines innovative small-molecule therapies with targeted biologics and digital health offerings. The company has collaborated with international partners to co-develop and co-market key therapies, and it continues to invest in clinical trials addressing unmet medical needs. Its nutraceutical business capitalizes on proprietary formulation technologies to create products aimed at hydration, energy support and general wellness.

Headquartered in Tokyo, Otsuka maintains a broad international footprint, with research and development centers, manufacturing sites and sales operations in North America, Europe, Asia and emerging markets. This global network supports localized regulatory filings and distribution, enabling the company to respond effectively to diverse healthcare environments and consumer preferences. Its supply-chain capabilities are designed to ensure consistent quality and timely delivery of its pharmaceutical and consumer offerings.

Tracing its roots back to the early 20th century as a chemical company, Otsuka Pharmaceutical Co., Ltd. was formally established in the 1960s and has since evolved into the cornerstone of the Otsuka Holdings group. The firm is guided by an experienced leadership team led by its President and Representative Director, who together oversee strategic investments in R&D, partnerships and digital health initiatives. Through a commitment to innovation and patient-centric solutions, Otsuka continues to build on its heritage of scientific expertise and global collaboration.

Key Stats

• Today's Range: $50.73 to $50.73
• 50-Day Range: $47.37 to $51.68
• 52-Week Range: $45.77 to $66.15
• Volume: 40 shs
• Average Volume: 1,078 shs
• Market Capitalization: N/A
• P/E Ratio: 0.17
• Dividend Yield: 109.95%
• Price Target: N/A
• Consensus Rating: N/A

Otsuka Stock Analysis - MarketRank™

Otsuka scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Otsuka.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Otsuka is 0.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.26.

Price to Earnings Ratio vs. Sector

The P/E ratio of Otsuka is 0.17, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.69.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 193.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Otsuka has recently increased by 30.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Otsuka pays a meaningful dividend of 3.45%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Otsuka does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Otsuka is 18.48%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Otsuka has a short interest ratio ("days to cover") of 193.5, which indicates bearish sentiment.

Change versus previous month

Short interest in Otsuka has recently increased by 30.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.19

News Sentiment

Otsuka has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.98 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Otsuka this week, compared to 2 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Otsuka insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 12.20% of the stock of Otsuka is held by institutions.

OTSKF Stock Analysis - Frequently Asked Questions

How have OTSKF shares performed this year?

Otsuka's stock was trading at $57.15 at the beginning of 2025. Since then, OTSKF stock has decreased by 11.2% and is now trading at $50.73.

How do I buy shares of Otsuka?

Shares of OTSKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/15/2025
• Next Earnings (Estimated): 7/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - General
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OTSKF
• CIK: 1544613
• Web: www.otsuka.com
• Phone: (136) 717-1410
• Fax: N/A
• Employees: 34,388
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.17
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A